Mad Money: Key points from January 24, 2023 (Tuesday) episode

This page contains summary of CNBC program “Mad Money w/ Jim Cramer” which was on air on Tuesday, January 24, 2023.  It also contains links to CNBC sites which contain video clips and transcripts.

(1) Jim Cramer says to consider an analyst’s call timeframe when investing (https://www.cnbc.com/2023/01/24/jim-cramer-says-to-consider-an-analysts-call-timeframe-when-investing.html)

• CNBC’s Jim Cramer on Tuesday reminded investors to pay close attention to the scope of an analyst’s calls.
• He used recent notes on Advanced Micro Devices to illustrate his point.

Ticker: AMD, QCOM, NVDA

(2) NASCAR President on the state of advertising demand (https://www.cnbc.com/video/2023/01/24/nascar-president-on-the-state-of-advertising-demand.html)

Cramer spoke with NASCAR President Steve Phelps and Jeff Gordon, vice chairman of Hendrick Motorsports, on Tuesday.

(3) [No Video Clip] Jim Cramer breaks down SLB’s, Baker Hughes’s and Halliburton’s quarterly earnings reports (https://www.cnbc.com/video/2023/01/24/jim-cramer-breaks-down-slbs-baker-hughess-and-halliburtons-quarterly-earnings-reports.html)

Cramer broke down the most recent quarterly earnings reports from SLB, Baker Hughes and Halliburton.

Ticker: SLB, HAL, BKR

(3)’ Cramer breaks down SLB’s fourth-quarter earnings (https://www.cnbc.com/video/2023/01/24/cramer-breaks-down-slbs-fourth-quarter-earnings.html)

Cramer went over the oil company’s fourth-quarter earnings report on Tuesday.

(4) Executive Interview: Logitech CEO says he expects a rebound in gaming (https://www.cnbc.com/video/2023/01/24/logitech-ceo-says-he-expects-a-rebound-in-gaming.html)

Cramer spoke with Logitech CEO Bracken Darrell on Tuesday.

Ticker: LOGI

(5) Cramer’s lightning round: Amicus Therapeutics is an ideal spec (https://www.cnbc.com/2023/01/24/cramers-lightning-round-amicus-therapeutics-is-an-ideal-spec.html)

• Quantumscape Corp: “I think you should take the money and run.”
• Inmode Ltd: “It sells for incredibly cheap. … Frankly, I don’t get it, and that makes me want to look more into it, not just say buy.”
• Amicus Therapeutics Inc: “I think that that stock is an ideal spec.”
• Exact Sciences Corp: “They’re losing too much money, to be honest. I’m baffled. … That’s what I don’t like about it.”
• Array Technologies Inc: “I’ve been looking for a new way to play solar. … I think Array may be the way.”
• National Retail Properties Inc: “I like Realty Income. … That’s been my favorite.”

Ticker: QS, INMD, FOLD, EXAS, ARRY, NNN

(6) [No Video Clip] Jim Cramer discusses Johnson & Johnson’s fourth-quarter earnings report and Wall Street’s reaction to it (https://www.cnbc.com/video/2023/01/24/jim-cramer-discusses-johnson-johnsons-fourth-quarter-earnings-report-and-wall-streets-reaction-to-it.html)

Cramer broke down his thoughts on the company’s latest quarterly earnings report and how markets reacted to it.

Ticker: JNJ

Other Stocks Discussed (calls with audience): Wells Fargo (WFC), Realty Income (O) [terrific buy],  APA Corporation (APA)

Ref: Links to other sites that relate to episode of January 24, 2023

• Google Podcast (Sound）
• Internet Archive（Video & Texts per minute）

Disclaimer

****************************